Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Expired

Oncology – Breast Cancer

Pfizer Inc

Introduction

Conquer Cancer® , the ASCO Foundation and Pfizer Global Medical Grants are collaborating to offer a Quality Improvement grant funding opportunity to improve the quality of care and to help build capacity to address the needs of breast cancer (BC) patients in Sub-Saharan Africa. This grant program will support innovative projects to improve the quality of BC patient care in the select geographies in the region (please review eligibility section below).

Submissions addressing the expressed Areas of Interest with a measurable and sustainable positive impact on patients will be favored by the Scientific Review Committee (SRC).

This grant awards program was purposefully developed with the Sub-Saharan Africa Regional Council of ASCO expressly for the patients of the Sub-Saharan region.

Conquer Cancer is the lead organization for the review and evaluation of applications. Grant funding will be provided directly from Pfizer. Collectively, up to $1,000,000 is available to fund Quality Improvement projects under this RFP. The maximum grant budget is $80,000 with a term of 24 months.

Successful applicants to this RFP will be expected to share the initial results of their project with ASCO’s SubSaharan Africa Regional Council at a future grantee meeting to be convened by Conquer Cancer. In addition, awardees will be invited to participate in career development, education, and networking opportunities provided by Global Bridges Healthcare Alliance (https://globalbridges.org).

About Conquer Cancer, the ASCO Foundation

Conquer Cancer® , the ASCO Foundation, funds research for every cancer, every patient, everywhere. Since 1984, its Grants & Awards program has awarded more than $178 million through more than 8,600 grants and awards to improve cancer care and accelerate breakthroughs in clinical and translational oncology research. Conquer Cancer’s EveryGrant® program is an end-to-end, white label solution, helping organizations develop and deliver grants programs that attract the brightest researchers and make a difference for people with cancer everywhere. For more information, visit CONQUER.ORG

About ASCO Sub-Saharan Africa Regional Council

The Sub-Saharan Africa Regional Council works to address the specific needs and challenges faced by oncology professionals in the region. Council members serve as voices for their respective countries, facilitate engagement in ASCO’s global programs, and work with Society leadership and staff to tailor ASCO programs to best support members in the region.

About Pfizer Global Medical Grants

The mission of Pfizer Global Medical Grants is to accelerate the translation of science into quality patient care through independent grants, partnerships, and collaborations. Pfizer Global Medical Grants supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. For all independent grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. For more information, please visit https://www.pfizer.com/about/programs-policies/grants.

About Global Bridges

Global Bridges Healthcare Alliance, based at Mayo Clinic, is dedicated to supporting global communities of practice to advance evidence-based patient care. Since 2014, Global Bridges has worked collaboratively with Pfizer GMG to support medical education and quality improvement programs in multiple clinical areas, including oncology, tobacco dependence treatment, amyloidosis, and anti-microbial stewardship.

Specialties

Oncology

Cancer

Eligibility Requirements

To be eligible:

The institution, principal investigator (PI) and focus of the submission must be based in the following geographies:

Ghana
Senegal
Uganda
Zimbabwe
Ethiopia
Mozambique
Malawi
Rwanda
Zambia
Tanzania
Democratic Republic of Congo (DRC)
Mali
While applications must be submitted from the geographies noted above, collaborations with institutions outside of the region are permitted. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
Only organizations are eligible to receive grants, not individuals or physicianowned medical group practices.
Eligible institutions include Academic Cancer Centers, Healthcare Delivery Networks, large and small hospitals, academic medical centers, community hospitals, ambulatory care settings, and other facilities engaged the continuum of cancer care.
Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
The Project Lead/PI must be an employee or independent contractor of the requesting organization.
The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Pathology, Physiotherapy, Psychology, or Social Work. Additional advanced degrees may be considered on a case-by-case basis. Please contact staff noted on Page 7 with any eligibility inquiries.

Eligible Countries:

Sponsor Details

Sponsor Institute/Organizations: Pfizer Inc

Sponsor Type:

Address: Pfizer Inc;235 East 42nd Street NY 10017;United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity